P Pure Storage, Inc. Insider Trading

John Colgrove sells 100,000 shares at $79.82 blended price; -19.8% below 52-week high; 10b5-1 plan.

Chief Visionary Officer John Colgrove sold 100,000 shares (100.0K shares) totaling $7,982,329.01 via 8 separate sales on 2026-07-10, reducing his holdings from 2.66M to 2.56M shares. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2026-01-08, meaning the sale was scheduled rather than discretionary. At the blended average price of $79.82, the sale occurred 19.8% below the 52-week high of $93.92, with the current stock price at $75.36. The company's fundamentals show annual revenue growth of 15.6% and a P/E of 110.82, though the elevated valuation multiple deserves attention. His prior trades at this ticker (5 prior sales) generated positive 30-day returns ranging from 10.9% to 13.3%, though outcomes beyond 30 days remain unmeasurable.

Everpure CEO Charles H Giancarlo sells 135,800 shares for $10,915,063.30 via scheduled 10b5-1 plan; stock down 19.8% from 52-week high at $75.36.

Charles H Giancarlo, CEO of Everpure, Inc., executed 4 separate sales totaling 135,800 shares for $10,915,063.30 over 2026-07-09 to 2026-07-10, reducing his holdings from 1,815,397 to 1,679,597 shares. This transaction was completed under a pre-arranged 10b5-1 trading plan adopted on 2025-09-26, making it scheduled rather than discretionary. The blended average sale price was $80.38, while the current stock price of $75.36 is 19.8% below the 52-week high of $93.92. His prior trades at Everpure show consistently negative 30-day returns (ranging from -20.3% to -27.2%), establishing a pattern of post-sale price declines at this specific ticker; however, the current filing's 10b5-1 structure removes any inference about discretionary timing. With a P/E of 110.82 and annual revenue growth of +15.6%, investors should evaluate whether the valuation and scheduled selling pressure create offsetting signals.

CPO Ajay Singh sells 9,787 Everpure shares at $78.12; retains 340,939 shares. Stock up 19.2% in 30 days.

Ajay Singh sold 9,787 shares (2.8% of pre-transaction holdings) at $78.12, leaving him with 340,939 shares post-transaction. The sale occurred as the stock is up 19.2% over the trailing 30 days and trades at current price $79.33, approximately 15.5% below its 52-week high of $93.92. Singh's cross-ticker track record shows 5 prior sells with an average 90-day return of +2.0% and a 60.00% well-timed rate, indicating his sales have historically been executed ahead of subsequent stock appreciation (poorly-timed outcomes). The transaction size relative to total holdings is modest; Everpure's valuation metrics show a P/E of 116.66 against quarterly revenue of $1.1B and net income of $24.1M, reflecting a high-growth but expensive multiple structure.

CVO John Colgrove sold 100,000 shares for $7.1M at blended avg $71.04 under 10b5-1 plan; retains 2.62M shares post-sale.

John Colgrove executed 5 separate sales totaling 100,000 shares for $7,103,769.46 at prices ranging from $70.00 to $71.54, representing a -3.7% reduction in his holdings to 2,615,000 shares. The transaction was executed under a pre-arranged 10b5-1 trading plan adopted on 2026-01-08, indicating the sales were scheduled rather than discretionary. Stock price has declined -14.4% over the past 30 days and stands -23.0% from its 52-week high of $93.92, though his prior 5 same-ticker sales at this company all occurred on 2026-05-11 and showed 30-day post-sale declines ranging from -23.0% to -25.4%. The scheduled nature of this transaction removes any timing signal; investors should note the pattern of post-sale price weakness in his prior same-ticker trades but recognize this filing reflects a programmatic disposition plan rather than a discretionary market judgment.

CEO Giancarlo Charles H exercised and sold 580k shares in 11 separate tranches, netting $50.8M disposition versus $8.5M in stock awards.

CEO Giancarlo Charles H executed a substantial portfolio rebalancing on a single trading day: exercising 500,000 shares from equity awards and immediately selling 580,000 shares across 11 separate transactions, generating $50.8M in gross proceeds. The exercise and immediate sales pattern suggests the stock had risen meaningfully from the award grant level, allowing him to liquidate a large block at prices ranging upward. Notably, this is the CEO's first open-market sale activity at Everpure since the company went public (these 11 sales represent his first sale transactions on record at P). The stock currently trades well below its 52-week high despite the company's solid fundamentals—it remains profitable with growing revenue—suggesting the timing may reflect opportunistic liquidation during a period when the stock was relatively elevated. The sheer dollar volume and multi-tranche execution indicate deliberate, methodical liquidation rather than panic selling, and his continued substantial shareholding post-transaction suggests this does not represent a complete exit from the company.

Everpure Chief Visionary Officer John Colgrove executes 10b5-1 plan: 100,000 shares for $8.8M at blended $87.82

John Colgrove executed 20 separate sales totaling 100,000 shares for $8,781,932.87 on 2026-05-11 under a pre-arranged 10b5-1 trading plan adopted on 2026-01-08. This was a scheduled, non-discretionary disposition, reducing his post-transaction holdings to 2,665,000 shares (a -3.6% net change from pre-transaction holdings). The transaction occurred across a range of prices from $83.84 to $93.42, with a blended average of $87.82, slightly above the current price of $84.43 as of 2026-05-13. The recent IPO status of Everpure (18 trading days post-listing) and the high P/E of 131.92 against solid fundamentals—$964.5M quarterly revenue with +15.6% annual growth and $54.8M net income—provide context for the sale, though the 10b5-1 framework removes discretion from the timing.

CVO John Colgrove sold 134,265 shares over 3 days (May 5-7) for $10,088,483.74 at avg $75.14; retains 467,694 shares post-sale.

Colgrove executed 3 separate sales totaling 134,265 shares for $10,088,483.74 across May 5–7, 2026, reducing his stake by -22.3% versus pre-transaction holdings of 601,959 shares. The transaction prices ($75.12, $75.01, $75.31) clustered tightly around the blended average of $75.14, which compares closely to the current price of $74.43 as of 2026-05-06. The stock is a recent listing (14 trading days), limiting historical context; valuations remain elevated (P/E 130.58) relative to revenue growth (+15.6% annually) and profitability ($87.9M net income on $2.6B revenue). The large absolute dollar sale ($10.1M) by a Chief Visionary Officer warrants investor attention to motivation and timing context, though this filing alone does not resolve whether the sale reflects portfolio rebalancing or broader business signal.

Director liquidates complete stake in Everpure via large sale near 52-week highs

A director has sold their entire shareholding in Everpure, disposing of roughly twenty-nine thousand shares at a price near the company's recent peak. This complete exit is noteworthy because it signals the insider is stepping away entirely rather than making a routine rebalancing trade. The company itself is profitable with strong revenue growth and a track record of financial performance, which could suggest the insider is simply taking chips off the table at a favorable price rather than fleeing weakness. However, the stock's valuation appears stretched relative to earnings, which may have factored into the decision to sell at current levels. The timing—at or very near 52-week highs—is the critical detail: insiders typically liquidate when they view valuations as attractive, not when they're concerned about fundamental deterioration.

CPO Singh sells 7,014 PSTG shares at $85.85; retains 229.3K shares. Stock near 52-week highs.

Singh Ajay, Chief Product Officer of Pure Storage, sold 7,014 shares on 2025-09-24 at $85.85, reducing his holdings by 3.0% to 229.3K shares while retaining a substantial long position. The sale occurred when the stock was -6.7% from its 52-week high of $88.29, following a strong 30-day rally of +35.4% and 90-day rise of +48.7%. At PSTG specifically, Singh's prior sales show mixed timing: the 2024-12-31 sale saw a 90-day decline of -28.1%, but the 2024-04-05 sale gained +19.0% over 90 days; overall, only 1 of 3 prior measurable 90-day outcomes at this ticker were well-timed. The company carries a notably elevated P/E of 196.19 relative to recent profitability, though revenue grew +11.9% year-over-year. This is a routine insider sale by a senior executive during a period of elevated valuations and strong recent momentum.

PSTG CRO Dan FitzSimons sold 6,051 shares at $87.42 for $528,978.42; holds 62,759 shares post-sale.

Dan FitzSimons, Chief Revenue Officer, sold 6,051 shares (8.8% of his pre-transaction holdings) at $87.42, reducing his stake from 68,810 to 62,759 shares. The sale occurred near the 52-week high of $88.29, and his cross-ticker track record shows a 60.00% well-timed rate on prior sells with an average 90-day return of 4.0%. At PSTG specifically, his timing has been mixed: 3 of 5 prior sells showed negative 90-day returns (well-timed), but his most recent PSTG sale on 2024-12-24 was poorly timed, with the stock returning +12.9% in 30 days and -17.5% in 90 days after the sale. The current transaction occurs as PSTG trades at an elevated valuation (P/E 210.21) following a sharp 30-day gain of +51.4%, which may reflect profit-taking rather than fundamental concern. The CRO's continued substantial holdings (62.8K shares) suggest maintained alignment with the company.